46.88
+0.77(+1.67%)
Currency In USD
| Previous Close | 46.11 |
| Open | 46.29 |
| Day High | 47.06 |
| Day Low | 46.02 |
| 52-Week High | 65.03 |
| 52-Week Low | 38.27 |
| Volume | 190,609 |
| Average Volume | 826,284 |
| Market Cap | 2.67B |
| PE | -21.21 |
| EPS | -2.21 |
| Moving Average 50 Days | 46.08 |
| Moving Average 200 Days | 45.91 |
| Change | 0.77 |
If you invested $1000 in Enovis Corporation (ENOV) 10 years ago, it would be worth $558.94 as of February 05, 2025 at a share price of $46.88. Whereas If you bought $1000 worth of Enovis Corporation (ENOV) shares 5 years ago, it would be worth $719.99 as of February 05, 2025 at a share price of $46.88.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
GlobeNewswire Inc.
Jan 29, 2025 12:00 PM GMT
Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and
Enovis™ Announces Leadership Change to International Surgical Business
GlobeNewswire Inc.
Jan 17, 2025 11:00 AM GMT
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann as President of Enovis International Su
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 06, 2025 9:15 PM GMT
Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 43nd Annual J.P. Morgan Healthcare